TD Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-28,800
| Closed | -$404K | – | 1388 |
|
|
2015
Q3 | $404K | Buy |
28,800
+1,000
| +4% | +$14K | ﹤0.01% | 1124 |
|
|
2015
Q2 | $472K | Buy |
27,800
+2,900
| +12% | +$49.2K | ﹤0.01% | 1130 |
|
|
2015
Q1 | $301K | Sell |
24,900
-7,400
| -23% | -$89.5K | ﹤0.01% | 1240 |
|
|
2014
Q4 | $268K | Sell |
32,300
-21,300
| -40% | -$177K | ﹤0.01% | 1261 |
|
|
2014
Q3 | $466K | Sell |
53,600
-26,100
| -33% | -$227K | ﹤0.01% | 1057 |
|
|
2014
Q2 | $873K | Sell |
79,700
-35,400
| -31% | -$388K | ﹤0.01% | 917 |
|
|
2014
Q1 | $1.03M | Buy |
115,100
+9,500
| +9% | +$84.9K | ﹤0.01% | 904 |
|
|
2013
Q4 | $796K | Buy |
105,600
+1,600
| +2% | +$12.1K | ﹤0.01% | 916 |
|
|
2013
Q3 | $762K | Buy |
104,000
+5,600
| +6% | +$41K | ﹤0.01% | 910 |
|
|
2013
Q2 | $633K | Buy |
+98,400
| New | +$633K | ﹤0.01% | 895 |
|